At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NAGE Niagen Bioscience
Trading 03-25 14:35:56 EDT
4.54
+0.00
0.00%
High4.65Low4.54Vol366.92K
Open4.58D1 Closing4.54Amplitude2.42%
Mkt Cap362.84MTradable Cap233.42MTotal Shares79.92M
T/O1.69MT/O Rate0.71%Tradable Shares51.41M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Niagen Bioscience Doubles Share Repurchase Authorization to $20M
TIPRANKS  ·  03-19
Niagen Bioscience Doubles Share Repurchase Authorization to $20M
Niagen Bioscience increases share repurchase program to $20M
TIPRANKS  ·  03-19
Niagen Bioscience increases share repurchase program to $20M
Niagen Bioscience Increases Share Repurchase Program to $20 Million
THOMSON REUTERS  ·  03-19
Niagen Bioscience Increases Share Repurchase Program to $20 Million
Niagen Bioscience to present at the 38th Annual ROTH Conference
Reuters  ·  03-18
Niagen Bioscience to present at the 38th Annual ROTH Conference
Niagen Bioscience tops 300 external research agreements for Niagen and cites 45 published clinical studies
Reuters  ·  03-17
Niagen Bioscience tops 300 external research agreements for Niagen and cites 45 published clinical studies
Niagen Bioscience Surpasses 300 External Research Agreements From Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies
THOMSON REUTERS  ·  03-17
Niagen Bioscience Surpasses 300 External Research Agreements From Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies
Niagen Bioscience launches Niagen Skincare Innovation Lab and debuts Niagen NanoCloud topical product
Reuters  ·  03-10
Niagen Bioscience launches Niagen Skincare Innovation Lab and debuts Niagen NanoCloud topical product
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity
Dow Jones  ·  03-06
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity
Niagen Bioscience Inc. Releases Transcript of Fourth Quarter 2025 Earnings Conference Call
Reuters  ·  03-06
Niagen Bioscience Inc. Releases Transcript of Fourth Quarter 2025 Earnings Conference Call
Top Premarket Gainers
MT Newswires Live  ·  03-05
Top Premarket Gainers
Niagen Bioscience price target lowered to $13 from $14 at Canaccord
TIPRANKS  ·  03-05
Niagen Bioscience price target lowered to $13 from $14 at Canaccord
Niagen Bioscience Rallies 18% After Hours: Here's Why
Benzinga  ·  03-05
Niagen Bioscience Rallies 18% After Hours: Here's Why
Niagen Bioscience Inc. Publishes Investor Presentation on NAD+ and Healthy Aging Strategy
Reuters  ·  03-05
Niagen Bioscience Inc. Publishes Investor Presentation on NAD+ and Healthy Aging Strategy
Niagen Bioscience sees FY26 revenue up 10%-15%, implying $142.3M-$148.8M
TIPRANKS  ·  03-05
Niagen Bioscience sees FY26 revenue up 10%-15%, implying $142.3M-$148.8M
Niagen Bioscience up 39% at $6.88 after Q4 results and guidance
TIPRANKS  ·  03-05
Niagen Bioscience up 39% at $6.88 after Q4 results and guidance
Niagen Bioscience Q4 net sales rise
Reuters  ·  03-05
Niagen Bioscience Q4 net sales rise
Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion
Benzinga  ·  03-05
Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion
Niagen Bioscience Q4 EPS $0.05 Beats $0.02 Estimate, Sales $33.839M Beat $31.705M Estimate
Benzinga  ·  03-05
Niagen Bioscience Q4 EPS $0.05 Beats $0.02 Estimate, Sales $33.839M Beat $31.705M Estimate
Niagen Bioscience posts FY 2025 net income up 2.0x to USD 17.4 million
Reuters  ·  03-05
Niagen Bioscience posts FY 2025 net income up 2.0x to USD 17.4 million
BRIEF-Niagen Bioscience Inc Q4 Sales USD 33.839 Million Vs. IBES Estimate USD 31.7 Million
Reuters  ·  03-05
BRIEF-Niagen Bioscience Inc Q4 Sales USD 33.839 Million Vs. IBES Estimate USD 31.7 Million

Introduction

Company Name.
Niagen Bioscience
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--